title: Mineralisation defects after pamidronate for Paget's disease.
authors.forename: B F
authors.initials: BF
authors.lastname: Boyce
authors.forename: B B
authors.initials: BB
authors.lastname: Adamson
authors.forename: S J
authors.initials: SJ
authors.lastname: Gallacher
authors.forename: J
authors.initials: J
authors.lastname: Byars
authors.forename: S H
authors.initials: SH
authors.lastname: Ralston
authors.forename: I T
authors.initials: IT
authors.lastname: Boyle
mesh_terms: D002113:Calcification, Physiologic / Q000187:drug effects; D004164:Diphosphonates / Q000009:adverse effects*; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000139:chemically induced; D010001:Osteitis Deformans / Q000188:drug therapy*; D010018:Osteomalacia / Q000139:chemically induced*; D000077268:Pamidronate
chemical_list: D004164:Diphosphonates; D000077268:Pamidronate